1Bo Li, Tian Ye, Lei Zhao, De-Hua Li, Xing-Hua Gou, Lan-Ying Zhao, Lei Han, Lin Chen, Lu-Nan Yan and Jian-Ping Gong Department of Hepatobiliary Surgery, Second Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 400010, China ,Department of Traditional Chinese Surgery, Second Affiliated Hospital, Luzhou Medical College, Luzhou 646000, China ,Genetic Engineering Laboratory, Chengdu Di’ao Group Co., Ltd., Chengdu 610041, China Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):552-559. 被引量：10
5Carswoll E A, Old L J, Kassel R Let al. An endotoxin-in- dueed serum factor that causes necrosis of tumors [ J ]. Proc Natl Acad Sci, 1975, 72(9) : 3666.
6Chu W M. Tumor necrosis factor[J]. Cancer Lett, 2013, 328(2) : 222.
7Chen K J, Sikic B I. Molecular Pathways: Regulation and therapeutic implications of muhidrug Resistance[ J ]. C|in Cancer Res, 2012, 18(7) : 1863.
8Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives [ J ]. Curr Canc- er Drug Targets, 2013, 13(3) : 326.
9Lee SK, Shehzad A, Jung J C, et al. Protein kinase Cot pro- tects against multidrug resistance in human colon cancer cells [J]. Mol Cells, 2012, 34(1) :61.
10Ahmad S, Glazer R I. Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-re- sistant MCF-7 breast carcinoma cells [ J ]. Mol Pharmacol, 1993, 43 : 858.
